Primary Site >> Stomach Cancer

Gene >> IDO1

Journal: Mol Med Rep. 2011 Jan-Feb;4(1):169-73.
Title: Immunoactivative role of indoleamine 2,3dioxygenase in gastric cancer cells in vitro.
Author: Zhang, Rupeng|Li, Hui|Yu, Jinpu|Zhao, Jingzhu|Wang, Xuejun|Wang, Gang|Yao, Zhoujia|Wei, Feng|Xue, Qiang|Ren, Xiubao
PMID: 21461581
Journal: PLoS Pathog. 2013;9(5):e1003341.
Title: Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Author: Strong, Michael J|Xu, Guorong|Coco, Joseph|Baribault, Carl|Vinay, Dass S|Lacey, Michelle R|Strong, Amy L|Lehman, Teresa A|Seddon, Michael B|Lin, Zhen|Concha, Monica|Baddoo, Melody|Ferris, Marybeth|Swan, Kenneth F|Sullivan, Deborah E|Burow, Matthew E|Taylo
PMID: 23671415
Journal: Dig Dis Sci. 2013 Dec;58(12):3494-502.
Title: The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer.
Author: Zhang, Rupeng|Liu, Hui|Li, Fangxuan|Li, Hui|Yu, Jinpu|Ren, Xiubao
PMID: 23979437
Journal: Tumour Biol. 2014 Sep;35(9):8691-8.
Title: The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment.
Author: Li, Fangxuan|Huang, Jinchao|Li, Shixia|Li, Hui|Yu, Jinpu|Ren, Xiubao|Liu, Juntian
PMID: 24870595
Journal: Pharmacogenomics J. 2017 Dec;17(6):528-534.
Title: Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.
Author: Sunakawa, Y|Cao, S|Volz, N B|Berger, M D|Yang, D|Parekh, A|Zhang, W|Matsusaka, S|Ning, Y|Stremitzer, S|Stintzing, S|Sebio, A|Okazaki, S|Wakatsuki, T|Azuma, M|Watanabe, M|Koizumi, W|Wu, A H|Lenz, H-J
PMID: 27241062
Journal: BMC Cancer. 2017 Feb 15;17(1):133.
Title: Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer.
Author: Lozano-Pope, Ivonne|Sharma, Arnika|Matthias, Michael|Doran, Kelly S|Obonyo, Marygorret
PMID: 28201999
Journal: BMC Med Genomics. 2017 Dec 6;10(1):74.
Title: Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types.
Author: Budczies, Jan|Denkert, Carsten|Gyorffy, Balazs|Schirmacher, Peter|Stenzinger, Albrecht
PMID: 29212506
Journal: Gastroenterology. 2018 Jan;154(1):140-153.e17.
Title: Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.
Author: El-Zaatari, Mohamad|Bass, Adam J|Bowlby, Reanne|Zhang, Min|Syu, Li-Jyun|Yang, Yitian|Grasberger, Helmut|Shreiner, Andrew|Tan, Bei|Bishu, Shrinivas|Leung, Wai K|Todisco, Andrea|Kamada, Nobuhiko|Cascalho, Marilia|Dlugosz, Andrzej A|Kao, John Y
PMID: 28912017
Journal: Cancer Treat Rev. 2018 May;66:104-113.
Title: Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.
Author: Taieb, Julien|Moehler, Markus|Boku, Narikazu|Ajani, Jaffer A|Yanez Ruiz, Eduardo|Ryu, Min-Hee|Guenther, Silke|Chand, Vikram|Bang, Yung-Jue
PMID: 29730461
Journal: Anticancer Res. 2018 Jun;38(6):3387-3392.
Title: The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer.
Author: Nishi, Masaaki|Yoshikawa, Kozo|Higashijima, Jun|Tokunaga, Takuya|Kashihara, Hideya|Takasu, Chie|Ishikawa, Daichi|Wada, Yuma|Shimada, Mitsuo
PMID: 29848687